Pembrolizumab (Endometrial cancer): Solution concentrate for I.V. infusion 100 mg in 4 mL; Keytruda® - March 2022- March 2023 PBAC meetings Page last updated: 30 June 2023 Public Summary Document (PSD) March 2022 March 2023 PBAC Meetings - (PDF 1.1MB) Public Summary Document (PSD) March 2022 March 2023 PBAC Meetings - (Word 796KB)